Published August 19, 2015 This content is archived.
An article in International Business Times about FDA approval of Addyi, the first drug to boost sexual desire in women quotes Vanessa Barnabei, director of obstetrics and gynecology at UB, who said it takes time for doctors to get to know a patient well enough to diagnose hypoactive sexual desire disorder accurately by ruling out that her desire isn’t waning due to other issues. “Busy ob-gyns just don’t want to be spending the time to really ferret out those differences,” she said. “It’s hard and its time-consuming and you don’t get a lot of compensation for those visits.
Read more:
Media Relations (University Communications)
330 Crofts Hall (North Campus)
Buffalo, NY 14260-7015
Tel: 716-645-6969
ub-news@buffalo.edu